|
- Home page | Biomarker Research
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines
- Articles | Biomarker Research
Biomarker Research encompasses every aspect of biomarker investigation from all biomedical disciplines The journal recognizes that the study of biomarkers
- Targeting the chemokine receptor CXCR4 for cancer therapies - Biomarker . . .
The C-X-C chemokine receptor type 4 (CXCR4) has emerged as a key molecular biomarker for cancer therapies due to its critical role in tumor progression and metastases by displaying a stem cells phenotype
- About | Biomarker Research
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines
- The overlooked trio: sleep duration, sampling time and physical . . .
Our findings highlight how dynamic physiology can modulate CVD biomarker levels These results also underscore the need to consider sleep duration as a key determinant of cardiovascular health—an emphasis reflected in recent American Heart Association guidelines
- Circulating tumor DNA for MRD detection in colorectal cancer: recent . . .
In conclusion, ctDNA MRD is a promising biomarker for mCRC that can provide real-time information on tumor dynamics and molecular characteristics It has shown clinical utility in predicting prognosis and treatment response in patients with mCRC
- The evolving landscape of biomarkers for systemic therapy in advanced . . .
Biomarker exploration procedure for systemic therapy of HCC include collection of samples, assay of biomarkers and analysis of outcomes Specimens sources included noninvasive and invasive methods
- Microfluidic biosensors for biomarker detection in body fluids: a key . . .
This review focuses on recent advances in microfluidic biosensors from 2018 to 2024, detailing their operational principles, fabrication techniques, and integration with nanotechnology for cancer biomarker detection
|
|
|